Jia Liu
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies 17
- SARS-CoV-2 and COVID-19 Research 14
- Hepatology top 1%
- Hepatitis C virus research 24
- Biomaterials top 1%
- Neurology top 2%
- Long-Term Effects of COVID-19 11
- Molecular Medicine top 2%
-
- Hepatitis B Virus Studies 39
- Liver Disease Diagnosis and Treatment 14
-
- Immune Cell Function and Interaction 11
- Immune Response and Inflammation 10
- Journals
- Nature (1 paper)SHILAP Revista de lepidopterología (1 paper)The Journal of Immunology (3 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Jia Liu
125 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Infectious Diseases 1.8k
- Hepatology 546
- Biomaterials 769
- Neurology 681
- Molecular Medicine 187
Countries citing papers authored by Jia Liu
This map shows the geographic impact of Jia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Liu more than expected).
Fields of papers citing papers by Jia Liu
This network shows the impact of papers produced by Jia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Liu. The network helps show where Jia Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jia Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 2 | |
| 8 | Structural and mechanistic insights into fungal β-1,3-glucan synthase FKS1breakdown → | 2023 | 102 |
| 9 | 2023 | 18 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 14 | |
| 12 | 2020 | 98 | |
| 13 | 2020 | 296 | |
| 14 | 2020 | 10 | |
| 15 | 2020 | 17 | |
| 16 | 2019 | 9 | |
| 17 | 2019 | 53 | |
| 18 | 2017 | 18 | |
| 19 | 2016 | 3 | |
| 20 | 2015 | 14 |
About Jia Liu
Jia Liu is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 128 papers that have together received 4.9k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (39 papers), Hepatitis C virus research (24 papers), COVID-19 Clinical Research Studies (17 papers), SARS-CoV-2 and COVID-19 Research (14 papers), Liver Disease Diagnosis and Treatment (14 papers), Immune Cell Function and Interaction (11 papers), Long-Term Effects of COVID-19 (11 papers) and Immune Response and Inflammation (10 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Hepatology (546 citations) and Biomaterials (769 citations). Jia Liu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Mengji Lu, Dongliang Yang, Xin Zheng, Ling Xu, Lin Wang, Zheng Wang, Ulf Dittmer, Lei Huang, Baoju Wang and Mirko Trilling. Their work appears in journals such as Nature, SHILAP Revista de lepidopterología and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.